Vanta Bioscience IPO

Vanta Bioscience IPOBusiness description from prospectus – Vanta Bioscience is a preclinical contract research organization, offering a host of preclinical safety assessment services for clientele from Pharmaceutical, Medical Devices, Nutraceuticals, Feed Additive, Biotech, Agrochemicals, Cosmetics, and Chemical industries. In addition it also provides risk assessment services for evaluating the safety of the Active Pharmaceutical Ingredients (API), excipients, extractable and leachables including pharmaceutical impurities resulting due to manufacturing process or due to degradation of the product. VBS also provides expert services for determination of health based exposure limits (e.g. permitted daily exposure (PDE) or allowable daily exposure (ADE) including occupational exposure limits (OEL) for pharmaceutical manufacturers.

Promoters of Vanta Bioscience – Mohan Krishna Mulakala, Dopesh Raja Mulakala, Dr. Vyasmurti Madhavrao Shingatgeri, Dr. Soumya Simhadri, Shravan Chintapatla, Karishma Mulakala, Sajan Kiran Mulakala, Pradeep Chowdary, and Dr. Chandrasekhar Rao Simhadri

Vanta Bioscience IPO details

Subscription Dates 25 - 27 September 2017
IPO Price band INR50 per share
Fresh issue 1,512,000 shares (INR7.56 crore)
Offer for sale Nil
Total IPO size 1,512,000 shares (INR7.56 crore)
Minimum bid (lot size) 3,000 shares
Face Value  INR10 per share
Retail Allocation 50%
Listing On BSE SME platform

Vanta Bioscience's financial performance - FY 2017 is the first financial year of the Company and the Company has not carried any operations during the period covered under this Restated Financial Report. Hence no profit and loss statement has been prepared.

Vanta Bioscience Limited
NO.02/G/308/G, NO.3/FF/SF/1-20-248
Umajay Complex, Rasoolpura,
Secunderabad, Hyderabad – 500 003

Phone: +91 40 6657 5454
Email: [email protected]
Website: www.vantabio.com

Day

Subscription (no. of times)

Day 1 0.16
Day 2 0.31
Day 3 1.41

 

Earnings Per Share (EPS): Not available

Price/Earnings (P/E) ratio: Not available

Return on Net Worth (RONW): Not available

Net Asset Value (NAV): INR16.71 per share

Bigshare Services Private Limited 
E2, Ansa Industrial Estate, Sakivihar Road,
Sakinaka, Andheri (E),
Mumbai – 400 072

Phone: +91 22 4043 0200 
Fax: 
+91 22 2847 5201
Email:
 [email protected]
Website: www.bigshareonline.com

Vanta Bioscience IPO allotment status will be available on Bigshare Services' website. Click on this link to get allotment status.

IPO Opening Date: 25 September 2017

IPO Closing Date: 27 September 2017

Listing Date: 6 October 2017

Listing Price on BSE SME: INR51.1 per share (up 2.2% from IPO price)

Closing Price on BSE SME: INR50.2 per share (up 0.4% from IPO price)

Vanta Bioscience IPO
Rate this post

Leave a Reply

Your email address will not be published. Required fields are marked *